Related Experiment Video

Updated: Feb 16, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.7K

Cholesterol Ester Transfer Protein Inhibitor Review

Jerry Hu1, Scot Walker2

  • 1St. Louis College of Pharmacy, MO, USA.

Hospital Pharmacy
|December 26, 2017
PubMed

Insights

Cholesterol ester transfer protein (CETP) inhibitors, like anacetrapib, offer a new strategy to reduce atherosclerotic cardiovascular disease (ASCVD) risk. The REVEAL trial showed anacetrapib successfully reduced cardiovascular events, addressing residual risk beyond statin therapy.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biochemistry

Background:

  • Managing blood cholesterol is crucial for lowering atherosclerotic cardiovascular disease (ASCVD) risk.
  • HMG-CoA reductase inhibitors (statins) are primary treatments, but residual risk persists.
  • Cholesterol ester transfer protein (CETP) inhibitors are being investigated as a novel therapeutic strategy.

Purpose of the Study:

  • To evaluate the efficacy of CETP inhibitors in modifying lipid profiles.
  • To determine if CETP inhibition can reduce cardiovascular events in patients with residual risk.
  • To assess the specific impact of anacetrapib on cardiovascular outcomes.

Main Methods:

  • Investigated the use of cholesterol ester transfer protein (CETP) inhibitors.
  • Focused on agents designed to increase high-density lipoprotein cholesterol (HDL-C) and decrease low-density lipoprotein cholesterol (LDL-C).
  • Analyzed data from large-scale clinical trials, including the REVEAL trial for anacetrapib.

Main Results:

  • Initial CETP inhibitor studies showed no reduction in cardiovascular events.
  • Anacetrapib, a specific CETP inhibitor, demonstrated a significant reduction in cardiovascular events in the REVEAL trial.
  • This suggests a potential role for anacetrapib in managing residual ASCVD risk.

Conclusions:

  • Anacetrapib represents a promising therapeutic option for reducing cardiovascular events.
  • CETP inhibition, specifically with anacetrapib, can address residual ASCVD risk not fully managed by current therapies.
  • Further research into CETP inhibitors may yield new strategies for cardiovascular disease prevention.

Keywords:
cardiovasculardrug informationformulary management/P&Tinvestigational drugs

More Related Videos

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.5K
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.6K
Acid Halides to Esters: Alcoholysis01:12

Acid Halides to Esters: Alcoholysis

Alcoholysis is a nucleophilic acyl substitution reaction in which an alcohol functions as a nucleophile. Acid halides react with alcohol to produce esters. The mechanism proceeds in three steps:
4.1K
Esters to Alcohols: Hydride Reductions01:17

Esters to Alcohols: Hydride Reductions

Esters are reduced to primary alcohols when treated with a strong reducing agent like lithium aluminum hydride. The reaction requires two equivalents of the reducing agent and proceeds via an aldehyde intermediate.
Lithium aluminum hydride is a source of hydride ions and functions as a nucleophile. The mechanism proceeds in three steps. Firstly, the nucleophilic hydride ion attacks the carbonyl carbon of the ester to form a tetrahedral intermediate. Subsequently, the carbonyl group re-forms,...
4.8K